Molecular formula: | C50H92N26O32S3 |
Average mass: | 1665.616 |
Monoisotopic mass: | 1664.553308 |
ChemSpider ID: | 34985959 |
14 of 14 defined stereocentres
Double-bond stereo
(3R,4R)-3,6-Diamino-N-{(3S,6Z,9S,12S,15S)-6-[(carbamoylamino)methylen]-9,12-bis(hydroxymethyl)-3-[(2E,4R)-2-iminohexahydro-4-pyrimidinyl]-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl} -4-hydroxyhexanamidsulfat (2:3) (non-preferred name)
[German]
[ACD/IUPAC Name](3R,4R)-3,6-Diamino-N-{(3S,6Z,9S,12S,15S)-6-[(carbamoylamino)methylen]-9,12-bis(hydroxymethyl)-3-[(4R)-2-iminohexahydro-4-pyrimidinyl]-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl}-4- hydroxyhexanamidsulfat (2:3) (non-preferred name)
[German]
[ACD/IUPAC Name](3R,4R)-3,6-Diamino-N-{(3S,6Z,9S,12S,15S)-6-[(carbamoylamino)methylene]-9,12-bis(hydroxymethyl)-3-[(2E,4R)-2-iminohexahydro-4-pyrimidinyl]-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl }-4-hydroxyhexanamide sulfate (2:3) (non-preferred name)
[ACD/IUPAC Name](3R,4R)-3,6-Diamino-N-{(3S,6Z,9S,12S,15S)-6-[(carbamoylamino)méthylène]-9,12-bis(hydroxyméthyl)-3-[(2E,4R)-2-iminohexahydro-4-pyrimidinyl]-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadécan-15-yl }-4-hydroxyhexanamide sulfate (2:3) (non-preferred name)
[French]
[ACD/IUPAC Name](3R,4R)-3,6-Diamino-N-{(3S,6Z,9S,12S,15S)-6-[(carbamoylamino)methylene]-9,12-bis(hydroxymethyl)-3-[(4R)-2-iminohexahydro-4-pyrimidinyl]-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl}-4 -hydroxyhexanamide sulfate (2:3) (non-preferred name)
[ACD/IUPAC Name](3R,4R)-3,6-Diamino-N-{(3S,6Z,9S,12S,15S)-6-[(carbamoylamino)méthylène]-9,12-bis(hydroxyméthyl)-3-[(4R)-2-iminohexahydro-4-pyrimidinyl]-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadécan-15-yl}-4 -hydroxyhexanamide sulfate (2:3) (non-preferred name)
[French]
[ACD/IUPAC Name]ENVIOMYCIN SULFATE
53760-33-1
[RN]67846BXW65
[UNII]